BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22183996)

  • 1. [A safety study of retinal toxicity after serial intravitreal injections of infliximab in rabbits eyes].
    Rassi AR; Rigueiro MP; Isaac DL; Dourado L; Abud MB; Freitas EC; Carneiro LB; Avila MP
    Arq Bras Oftalmol; 2011; 74(5):352-6. PubMed ID: 22183996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
    Giansanti F; Ramazzotti M; Vannozzi L; Rapizzi E; Fiore T; Iaccheri B; Degl' Innocenti D; Moncini D; Menchini U
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1151-6. PubMed ID: 18326743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal administration of the anti-TNF monoclonal antibody infliximab in the rabbit.
    Theodossiadis PG; Liarakos VS; Sfikakis PP; Charonis A; Agrogiannis G; Kavantzas N; Vergados IA
    Graefes Arch Clin Exp Ophthalmol; 2009 Feb; 247(2):273-81. PubMed ID: 18982345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab exerts a dose-dependent effect on retinal safety in the albino rabbit.
    Zayit-Soudry S; Vainer I; Zemel E; Mimouni M; Rabena M; Pieramici DJ; Perlman I; Loewenstein A
    Doc Ophthalmol; 2017 Dec; 135(3):175-185. PubMed ID: 28825191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular toxicity of intravitreous adalimumab (Humira) in the rabbit.
    Manzano RP; Peyman GA; Carvounis PE; Kivilcim M; Khan P; Chevez-Barrios P; Takahashi W
    Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):907-11. PubMed ID: 18414888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal toxicity of garenoxacin.
    Esfahani MR; Kazi AA; Peyman GA; Dellacroce JT; Aydin E
    Retina; 2006 Feb; 26(2):182-6. PubMed ID: 16467675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retinal toxicity of intravitreal doxycycline. A pilot study].
    Aydin E; Kazi AA; Peyman GA; Esfahani MR; Muñoz-Morales A; Kivilcim M; Caro-Magdaleno M
    Arch Soc Esp Oftalmol; 2007 Apr; 82(4):223-8. PubMed ID: 17443427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of repeated intravitreous injections of antibiotics and dexamethasone.
    Yoshizumi MO; Bhavsar AR; Dessouki A; Kashani A
    Retina; 1999; 19(5):437-41. PubMed ID: 10546941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group.
    Wu L; Hernandez-Bogantes E; Roca JA; Arevalo JF; Barraza K; Lasave AF
    Retina; 2011 Feb; 31(2):298-303. PubMed ID: 21099452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal toxicity of intravitreal trastuzumab in a rabbit model: preliminary results of an experimental study.
    Moschos MM; Chatziralli IP; Kalogeropoulos C; Georgountzos V; Agapitos E
    J Ocul Pharmacol Ther; 2013 Oct; 29(8):754-9. PubMed ID: 23597072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events after intravitreal infliximab (Remicade).
    Giganti M; Beer PM; Lemanski N; Hartman C; Schartman J; Falk N
    Retina; 2010 Jan; 30(1):71-80. PubMed ID: 19996827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of high-dose intravitreal adalimumab (Humira) in the rabbit.
    Manzano RP; Peyman GA; Carvounis PE; Damico FM; Aguiar RG; Ioshimoto GL; Ventura DF; Cursino ST; Takahashi W
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):327-31. PubMed ID: 21668348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of intravitreal nepafenac in rabbits.
    Afrashi F; Hashas AS; Shahbazov C; Arici M; Yikilmaz MS; Deveci R; Karacali S; Sahar U
    J Ocul Pharmacol Ther; 2015 Feb; 31(1):43-50. PubMed ID: 25285465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal toxicity of intravitreal tenecteplase in the rabbit.
    Rowley SA; Vijayasekaran S; Yu PK; McAllister IL; Yu DY
    Br J Ophthalmol; 2004 Apr; 88(4):573-8. PubMed ID: 15031179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of intravitreal injection of bevacizumab in rabbit eyes.
    Feiner L; Barr EE; Shui YB; Holekamp NM; Brantley MA
    Retina; 2006 Oct; 26(8):882-8. PubMed ID: 17031287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of intravitreal clindamycin in albino rabbit eyes.
    Habot-Wilner Z; Mazza O; Shahar J; Massarweh A; Mann I; Loewenstein A; Perlman I
    Doc Ophthalmol; 2017 Oct; 135(2):133-146. PubMed ID: 28744691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of nontoxic concentrations of piperacillin/tazobactam for intravitreal application. An electroretinographic, histopathologic and morphometric analysis.
    Ozkiriş A; Evereklioglu C; Kontaş O; Oner AO; Erkiliç K
    Ophthalmic Res; 2004; 36(3):139-44. PubMed ID: 15103204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular toxicity of intravitreal tacrolimus.
    Passos E; Genaidy MM; Peyman GA
    Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.